• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向JAK2的SOCS3蛋白新型受限嵌合肽模拟物的构效关系研究

Structure-Activity Relationship Investigations of Novel Constrained Chimeric Peptidomimetics of SOCS3 Protein Targeting JAK2.

作者信息

La Manna Sara, Leone Marilisa, Mercurio Flavia Anna, Florio Daniele, Marasco Daniela

机构信息

Department of Pharmacy, Research Center on Bioactive Peptides (CIRPEB), University of Naples "Federico II", 80131 Naples, Italy.

Institute of Biostructures and Bioimaging (CNR), 80145 Naples, Italy.

出版信息

Pharmaceuticals (Basel). 2022 Apr 9;15(4):458. doi: 10.3390/ph15040458.

DOI:10.3390/ph15040458
PMID:35455455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9031227/
Abstract

SOCS3 (suppressor of cytokine signaling 3) protein suppresses cytokine-induced inflammation and its deletion in neurons or immune cells increases the pathological growth of blood vessels. Recently, we designed several SOCS3 peptidomimetics by assuming as template structures the interfacing regions of the ternary complex constituted by SOCS3, JAK2 (Janus Kinase 2) and gp130 (glycoprotein 130) proteins. A chimeric peptide named KIRCONG chim, including non-contiguous regions demonstrated able to bind to JAK2 and anti-inflammatory and antioxidant properties in VSMCs (vascular smooth muscle cells). With the aim to improve drug-like features of KIRCONG, herein we reported novel cyclic analogues bearing different linkages. In detail, in two of them hydrocarbon cycles of different lengths were inserted at positions i/i+5 and i/i+7 to improve helical conformations of mimetics. Structural features of cyclic compounds were investigated by CD (Circular Dichroism) and NMR (Nuclear Magnetic Resonance) spectroscopies while their ability to bind to catalytic domain of JAK2 was assessed through MST (MicroScale Thermophoresis) assay as well as their stability in biological serum. Overall data indicate a crucial role exerted by the length and the position of the cycle within the chimeric structure and could pave the way to the miniaturization of SOCS3 protein for therapeutic aims.

摘要

细胞因子信号转导抑制因子3(SOCS3)蛋白可抑制细胞因子诱导的炎症反应,其在神经元或免疫细胞中的缺失会增加血管的病理性生长。最近,我们以SOCS3、Janus激酶2(JAK2)和糖蛋白130(gp130)蛋白构成的三元复合物的界面区域为模板结构,设计了几种SOCS3拟肽。一种名为KIRCONG chim的嵌合肽,包括非连续区域,被证明能够与JAK2结合,并在血管平滑肌细胞(VSMC)中具有抗炎和抗氧化特性。为了改善KIRCONG的类药物特性,我们在此报告了带有不同连接键的新型环状类似物。具体而言,在其中两种类似物中,在i/i + 5和i/i + 7位置插入了不同长度的烃环,以改善模拟物的螺旋构象。通过圆二色性(CD)光谱和核磁共振(NMR)光谱研究了环状化合物的结构特征,同时通过微量热泳(MST)分析评估了它们与JAK2催化结构域结合的能力以及它们在生物血清中的稳定性。总体数据表明,嵌合结构中环的长度和位置发挥了关键作用,这可能为治疗目的的SOCS3蛋白小型化铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/199f/9031227/f26294e90118/pharmaceuticals-15-00458-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/199f/9031227/f8d5a7e639c6/pharmaceuticals-15-00458-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/199f/9031227/5a3ac2e8df2c/pharmaceuticals-15-00458-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/199f/9031227/585acbbcc9cf/pharmaceuticals-15-00458-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/199f/9031227/74f0d7254738/pharmaceuticals-15-00458-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/199f/9031227/f26294e90118/pharmaceuticals-15-00458-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/199f/9031227/f8d5a7e639c6/pharmaceuticals-15-00458-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/199f/9031227/5a3ac2e8df2c/pharmaceuticals-15-00458-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/199f/9031227/585acbbcc9cf/pharmaceuticals-15-00458-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/199f/9031227/74f0d7254738/pharmaceuticals-15-00458-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/199f/9031227/f26294e90118/pharmaceuticals-15-00458-g005.jpg

相似文献

1
Structure-Activity Relationship Investigations of Novel Constrained Chimeric Peptidomimetics of SOCS3 Protein Targeting JAK2.靶向JAK2的SOCS3蛋白新型受限嵌合肽模拟物的构效关系研究
Pharmaceuticals (Basel). 2022 Apr 9;15(4):458. doi: 10.3390/ph15040458.
2
Chimeric Peptidomimetics of SOCS 3 Able to Interact with JAK2 as Anti-inflammatory Compounds.能够与JAK2相互作用的SOCS 3嵌合肽模拟物作为抗炎化合物。
ACS Med Chem Lett. 2020 Mar 19;11(5):615-623. doi: 10.1021/acsmedchemlett.9b00664. eCollection 2020 May 14.
3
PEGylated SOCS3 Mimetics Encapsulated into PLGA-NPs as Selective Inhibitors of JAK/STAT Pathway in TNBC Cells.聚乙二醇化 SOCS3 模拟物包封于 PLGA-NPs 中,作为 TNBC 细胞中 JAK/STAT 通路的选择性抑制剂。
Int J Nanomedicine. 2024 Jul 18;19:7237-7251. doi: 10.2147/IJN.S441205. eCollection 2024.
4
Mimetics of suppressor of cytokine signaling 3: Novel potential therapeutics in triple breast cancer.细胞因子信号转导抑制因子 3 的模拟物:三阴性乳腺癌的新型潜在治疗药物。
Int J Cancer. 2018 Nov 1;143(9):2177-2186. doi: 10.1002/ijc.31594. Epub 2018 Aug 11.
5
Ad-hoc modifications of cyclic mimetics of SOCS1 protein: Structural and functional insights.SOCS1 蛋白的环状拟肽的即席修饰:结构和功能的见解。
Eur J Med Chem. 2022 Dec 5;243:114781. doi: 10.1016/j.ejmech.2022.114781. Epub 2022 Sep 19.
6
Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells.细胞因子信号转导抑制因子3对白细胞介素-6/干扰素-γ诱导的血管平滑肌细胞炎症细胞因子表达、迁移及增殖的抑制作用
J Huazhong Univ Sci Technolog Med Sci. 2013 Oct;33(5):615-622. doi: 10.1007/s11596-013-1168-x. Epub 2013 Oct 20.
7
Cyclic mimetics of kinase-inhibitory region of Suppressors of Cytokine Signaling 1: Progress toward novel anti-inflammatory therapeutics.细胞因子信号转导抑制因子 1 的激酶抑制区的环状模拟物:新型抗炎治疗的进展。
Eur J Med Chem. 2021 Oct 5;221:113547. doi: 10.1016/j.ejmech.2021.113547. Epub 2021 May 14.
8
Structure-activity studies of peptidomimetics based on kinase-inhibitory region of suppressors of cytokine signaling 1.基于细胞因子信号转导抑制因子1激酶抑制区域的拟肽的构效关系研究
Biopolymers. 2017 Nov 20. doi: 10.1002/bip.23082.
9
SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition.SOCS3 通过直接抑制激酶与特定的受体-JAK 复合物结合来控制细胞因子信号。
Nat Struct Mol Biol. 2013 Apr;20(4):469-76. doi: 10.1038/nsmb.2519. Epub 2013 Mar 3.
10
Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.组蛋白去乙酰化酶抑制剂丁酸钠通过抑制 HDAC8 介导的 SOCS1 和 SOCS3 的上调来抑制骨髓增殖性肿瘤中的 JAK2/STAT 信号通路。
Exp Hematol. 2013 Mar;41(3):261-70.e4. doi: 10.1016/j.exphem.2012.10.012. Epub 2012 Oct 27.

引用本文的文献

1
Discovery and biological evaluation of a novel and highly potent JAK2 inhibitor for the treatment of triple negative breast cancer.一种用于治疗三阴性乳腺癌的新型高效JAK2抑制剂的发现与生物学评价
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2488127. doi: 10.1080/14756366.2025.2488127. Epub 2025 Apr 29.
2
PEGylated SOCS3 Mimetics Encapsulated into PLGA-NPs as Selective Inhibitors of JAK/STAT Pathway in TNBC Cells.聚乙二醇化 SOCS3 模拟物包封于 PLGA-NPs 中,作为 TNBC 细胞中 JAK/STAT 通路的选择性抑制剂。
Int J Nanomedicine. 2024 Jul 18;19:7237-7251. doi: 10.2147/IJN.S441205. eCollection 2024.
3
Are peptidomimetics the compounds of choice for developing new modulators of the JAK-STAT pathway?

本文引用的文献

1
Proteomimetics of Natural Regulators of JAK-STAT Pathway: Novel Therapeutic Perspectives.JAK-STAT 信号通路天然调节剂的蛋白质模拟物:新的治疗前景
Front Mol Biosci. 2022 Jan 3;8:792546. doi: 10.3389/fmolb.2021.792546. eCollection 2021.
2
Optimization of Phosphotyrosine Peptides that Target the SH2 Domain of SOCS1 and Block Substrate Ubiquitination.优化靶向 SOCS1 SH2 结构域并阻断底物泛素化的磷酸酪氨酸肽。
ACS Chem Biol. 2022 Feb 18;17(2):449-462. doi: 10.1021/acschembio.1c00884. Epub 2022 Jan 6.
3
The JAK/STAT signaling pathway: from bench to clinic.
肽模拟物是开发 JAK-STAT 通路新调节剂的首选化合物吗?
Front Immunol. 2024 Jun 24;15:1406886. doi: 10.3389/fimmu.2024.1406886. eCollection 2024.
4
SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation.SOCS1 和 SOCS3 作为与皮肤炎症和恶性转化相关的免疫反应中的关键检查点分子。
Front Immunol. 2024 Jun 21;15:1393799. doi: 10.3389/fimmu.2024.1393799. eCollection 2024.
5
SOCS3 regulates pathological retinal angiogenesis through modulating SPP1 expression in microglia and macrophages.细胞因子信号转导抑制因子3(SOCS3)通过调节小胶质细胞和巨噬细胞中分泌性磷蛋白1(SPP1)的表达来调控病理性视网膜血管生成。
Mol Ther. 2024 May 1;32(5):1425-1444. doi: 10.1016/j.ymthe.2024.03.025. Epub 2024 Mar 19.
JAK/STAT 信号通路:从基础到临床。
Signal Transduct Target Ther. 2021 Nov 26;6(1):402. doi: 10.1038/s41392-021-00791-1.
4
Myeloid lineage contributes to pathological choroidal neovascularization formation via SOCS3.髓系细胞通过 SOCS3 促进病理性脉络膜新生血管形成。
EBioMedicine. 2021 Nov;73:103632. doi: 10.1016/j.ebiom.2021.103632. Epub 2021 Oct 21.
5
Emerging roles of suppressor of cytokine signaling 3 in human cancers.细胞因子信号转导抑制因子3在人类癌症中的新作用。
Biomed Pharmacother. 2021 Dec;144:112262. doi: 10.1016/j.biopha.2021.112262. Epub 2021 Oct 1.
6
SOCS: negative regulators of cytokine signaling for immune tolerance.SOCS:细胞因子信号负调控因子,参与免疫耐受。
Int Immunol. 2021 Nov 25;33(12):711-716. doi: 10.1093/intimm/dxab055.
7
IFN-γ inhibits ovarian cancer progression via SOCS1/JAK/STAT signaling pathway.IFN-γ 通过 SOCS1/JAK/STAT 信号通路抑制卵巢癌进展。
Clin Transl Oncol. 2022 Jan;24(1):57-65. doi: 10.1007/s12094-021-02668-9. Epub 2021 Jul 17.
8
Cyclic mimetics of kinase-inhibitory region of Suppressors of Cytokine Signaling 1: Progress toward novel anti-inflammatory therapeutics.细胞因子信号转导抑制因子 1 的激酶抑制区的环状模拟物:新型抗炎治疗的进展。
Eur J Med Chem. 2021 Oct 5;221:113547. doi: 10.1016/j.ejmech.2021.113547. Epub 2021 May 14.
9
Corneal Application of R9-SOCS1-KIR Peptide Alleviates Endotoxin-Induced Uveitis.角膜应用 R9-SOCS1-KIR 肽缓解内毒素诱导的葡萄膜炎。
Transl Vis Sci Technol. 2021 Mar 1;10(3):25. doi: 10.1167/tvst.10.3.25.
10
Protective effect of suppressor of cytokine signalling 1-based therapy in experimental abdominal aortic aneurysm.基于细胞因子信号传导抑制因子1的疗法在实验性腹主动脉瘤中的保护作用
Br J Pharmacol. 2021 Feb;178(3):564-581. doi: 10.1111/bph.15330. Epub 2020 Dec 23.